FoxWayne Enterprises Acquisition Corp.
Status: Liquidated
U=S+W
W=S@11.5
| IPO Proceeds, $M | $57.50M |
|---|---|
| IPO Date | Jan 20, 2021 |
| CEO | Robb Knie |
| Left Lead | EF Hutton |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 3 + 3 + 3 + 3 |
| IPO Sector |
Healthcare
Biotech, telemedicine, and technology in North America, with a focus on life sciences and pharmaceutical services |
| IPO Geography | US/Canada |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Jan 18, 2023 |
| Closing Date | Jan 27, 2023 |
FOXW
FOXWU
FOXWW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on FoxWayne Enterprises Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 30 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Robb Knie | 51 | Chairman, CEO and CFO |
| Michael Reavey | 44 | Director |
| Jeff Pavell | 63 | Director |
| Jonathan Hale Zippin | 44 | Director |
| Sundeep Agrawal | 35 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| EF Hutton | BR | 5,000,000 | units |
| 5,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.